PEG MGF

PEG MGF is described as a pegylated form of mechano-growth factor (MGF), an IGF-1 splice variant that is naturally upregulated in muscle after mechanical load or injury. The protocol emphasizes that, compared with systemic IGF-1, MGF is viewed as acting locally to initiate repair by activating muscle satellite cells and promoting local protein-synthesis signaling through its unique C-terminal “E peptide” domain, alongside classic IGF-1 receptor signaling. Pegylation is highlighted as a practical modification that extends the peptide’s half-life, enabling a once-daily subcutaneous protocol rather than frequent localized injections used with shorter-lived forms. The page summarizes animal and cell-based literature in which MGF analogs are associated with improved muscle regeneration and broader connective-tissue repair signals (including bone and cartilage healing) when administered over multiple weeks. Overall, the mechanism is muscle-repair initiation via satellite-cell activation plus extended exposure through pegylation.